The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Lobastov K.V.

Kafedra obshcheĭ khirurgii lechebnogo fakul'teta GOU VPO RGMU Roszdrava, Moskva

Dement’eva G.I.

N.I. Pirogov Russian National Research Medical University;
City Clinical Hospital No24, Moscow, Russia

Laberko L.A.

Kafedra obshcheĭ khirurgii lechebnogo fakul'teta Rossiĭskogo nauchno-issledovatel'skogo meditsinskogo universiteta im. N.I. Pirogova, Moskva

Current Insights on the Etiology and Pathogenesis of Venous Thrombosis: Virchow’s Triad Revision

Authors:

Lobastov K.V., Dement’eva G.I., Laberko L.A.

More about the authors

Journal: Journal of Venous Disorders. 2019;13(3): 227‑235

DOI: 10.17116/flebo201913031227

Read: 6231 times

Download PDF (RU)
Contact the author
Table of contents

CURRENT INSIGHTS ON THE ETIOLOGY AND PATHOGENESIS OF VENOUS THROMBOSIS: VIRCHOW’S TRIAD REVISION
CURRENT INSIGHTS ON THE ETIOLOGY AND PATHOGENESIS OF VENOUS THROMBOSIS: VIRCHOW’S TRIAD REVISION

To cite this article:

Lobastov KV, Dement’eva GI, Laberko LA. Current Insights on the Etiology and Pathogenesis of Venous Thrombosis: Virchow’s Triad Revision. Journal of Venous Disorders. 2019;13(3):227‑235. (In Russ.)
https://doi.org/10.17116/flebo201913031227

 
Подписка 2026 Флебология (Journal of Venous Disorders)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
The role of systemic and local immu­nity in the pathogenesis of endo­metriosis of varying degrees of prevalence of the process: a modern view. Russian Journal of Human Reproduction. 2024;(5):6-14
High mobi­lity group protein B1 (HMGB1) and the pote­ntial for inflammation amplification in preeclampsia and threatened preterm labor. Russian Journal of Human Reproduction. 2024;(5):82-88
Perioperative prevention of bleeding in glaucoma surgery. Russian Annals of Ophthalmology. 2024;(5):118-124
The rela­tionship between inflammatory markers, fati­gue, and effort-based deci­sion-making in patients at clinical high risk for psychosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):85-91
Modern view on the etiology of gallstone disease in children. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):59-68
Effi­cacy of alpha-glutamyl-tryptophan in the treatment of chro­nic atro­phic gastritis: case series. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):121-128
The role of neutrophils in the mechanisms of sepsis. Russian Journal of Archive of Pathology. 2024;(6):82-91
Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):81-90
Features of arte­rial blood flow velo­city characteristics in endo­thelial dysfunction. Russian Journal of Preventive Medi­cine. 2024;(12):100-106
Neuropeptide Y and inflammatory indi­ces in women after repeated cesa­rean section. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):35-40
Abstract:

A review of the current literature is devoted to the etiology and pathogenesis of venous thrombosis regarding their accordance with the classical Virchow’s triad. Three main components of venous stasis (reduced blood flow velocity, blood stagnation, vascular dilatation) and their effect on the endothelial function through shear stress are analyzed. The nature and diagnosis of hypercoagulation in surgery, pregnancy, hormonal medication intake, hyperhomocysteinemia, antiphospholipid syndrome and cancer are reviewed. We paid a particular attention to the role of microparticles in mechanisms of initiation and progression of thrombotic process. The role of endothelium in blood rheology, function of Weibel—Palade bodies and the role of adhesive molecules in initiation of thrombosis are discussed. We determined the role of neutrophils, neutrophil extracellular traps (NETs) and inflammatory reaction in genesis of thrombosis. We judged the compliance of all newly discovered pathogenetic mechanisms of thrombosis with the classical Virchow’s triad.

Keywords:

thrombosis
pathogenesis
venous stasis
hypercoagulation
endothelial dysfunction
microparticles
Weibel—Palade bodies
shear stress
inflammation
NETs

Authors:

Lobastov K.V.

Kafedra obshcheĭ khirurgii lechebnogo fakul'teta GOU VPO RGMU Roszdrava, Moskva

Dement’eva G.I.

N.I. Pirogov Russian National Research Medical University;
City Clinical Hospital No24, Moscow, Russia

Laberko L.A.

Kafedra obshcheĭ khirurgii lechebnogo fakul'teta Rossiĭskogo nauchno-issledovatel'skogo meditsinskogo universiteta im. N.I. Pirogova, Moskva

Close metadata

References:

  1. Savel’ev V, Kirienko A, Andriyashkin V, Zolotukhin I, Leont’ev S, Andriyashkin A. Itogi proekta «Territoriya bezopasnosti ot venoznykh tromboembolicheskikh oslozhnenii». Flebologiya. 2011;5(4):4-9. (In Russ.)
  2. Kirienko A.Profilaktika venoznykh tromboembolicheskikh oslozhnenii v khirurgicheskoi praktike. Klinicheskaya farmakologiya i terapiya. 2009;18(1):26-30. (In Russ.)
  3. Vardanyan A, Mumladze R, Belousov D, Roitman E. Kliniko-ekonomicheskii analiz profilaktiki posleoperatsionnykh venoznykh tromboembolicheskikh oslozhnenii. Kachestvennaya klinicheskaya praktika. 2018(1):51-63. (In Russ.)
  4. Hippisley-Cox J, Coupland C. Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study. BMJ. 2011;343:d4656. https://doi.org/10.1136/bmj.d4656
  5. Oger E. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d’Etude de la Thrombose de Bretagne Occidentale. Journal of Thrombosis and Haemostasis. 2000;83(5):657-660. https://doi.org/10.1055/s-0037-1613887
  6. Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrom J. Incidence and mortality of venous thrombosis: a population-based study. Journal of thrombosis and haemostasis: JTH. 2007;5(4):692-699. https://doi.org/10.1111/j.1538-7836.2007.02450.x
  7. White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I4-I8. https://doi.org/10.1161/01.CIR.0000078468.11849.66
  8. Cushman M, Tsai AW, White RH, Heckbert SR, Rosamond WD, Enright P, Folsom AR. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. The American journal of medicine. 2004;117(1):19-25. https://doi.org/10.1016/j.amjmed.2004.01.018
  9. Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. Journal of internal medicine. 1992;232(2):155-160. https://doi.org/10.1111/j.1365-2796.1992.tb00565.x
  10. Van Beek E, Buller H, Ten Cate J. Epidemiology of venous thromboembolism. A textbook of vascular medicine. London: Arnold, 1996;471-488.
  11. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ 3rd. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158(6):585-593. https://doi.org/10.1001/archinte.158.6.585
  12. Heit JA. The epidemiology of venous thromboembolism in the community: implications for prevention and management. J Thromb Thrombolysis. 2006;21(1):23-29. https://doi.org/10.1007/s11239-006-5572-y
  13. Obshchaya zabolevaemost’ vsego naseleniya Rossii v 2012 godu. Statisticheskie materialy. Chast’ II. 2013. Accepted 28.03.19. (In Russ.) Available from: http://www.rosminzdrav.ru/documents/8029-statisticheskaya-informatsiya-2012
  14. Zabolevaemost’ vsego naseleniya Rossii v 2014 g. Statisticheskie materialy. Chast’ II. 2015. Accepted 28.03.19. (In Russ.) Available from: https://www.rosminzdrav.ru/documents/9479-statisticheskaya-informatsiya-za-2014
  15. Zabolevaemost’ vsego naseleniya Rossii v 2016 g. Statisticheskie materialy. Chast’ II. 2017. Accepted 28.03.19. (In Russ.) Available from: https://www.rosminzdrav.ru/ministry/61/22/stranitsa-979/statisticheskie-i-informatsionnye-materialy/statisticheskiy-sbornik-2016-god.
  16. Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol. 2015;12(8):464-474. https://doi.org/10.1038/nrcardio.2015.83
  17. Anderson FAJr, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I9-16. https://doi.org/10.1161/01.CIR.0000078469.07362.E6
  18. Virchow R. Thrombose und Embolie: Gefässenzýndung und Septische Infektion, in Gesammelte Abhandlungen zur wissen schaftlichen Medicin. 1856. Meidinger, Sohn und Co: Frankfurt.
  19. Doran F, Drury M, Sivyer A. A simple way to combat the venous stasis which occurs in the lower limbs during surgical operations. British Journal of Surgery. 1964;51(7):486-492. https://doi.org/10.1002/bjs.1800510705
  20. Kemble JV. The effect of surgical operation on leg venous flow measured with radioactive hippuran. Postgrad Med J. 1971;47(554):773-776. https://doi.org/10.1136/pgmj.47.554.773
  21. Tripolitis AJ, Bodily KC, Blackshear WMJr, Cairols M, Milligan EB, Thiele BL, Strandness DEJr. Venous capacitance and outflow in the postoperative patient. Ann Surg. 1979;190(5):634-637. https://doi.org/10.1097/00000658-197911000-00012
  22. McLachlin AD, McLachlin JA, Jory TA, Rawling EG. Venous stasis in the lower extremities. Ann Surg. 1960;152:678-685. https://doi.org/10.1097/00000658-196010000-00011
  23. Nicolaides AN, Kakkar VV, Field ES, Spindler J. Soleal veins and stasis during operation. Br J Surg. 1972;59(4):304.
  24. Broderick BJ, O’Briain DE, Breen PP, Kearns SR, ÓLaighin G. A pilot evaluation of a neuromuscular electrical stimulation (NMES) based methodology for the prevention of venous stasis during bed rest. Medical engineering & physics. 2010;32(4):349-355. https://doi.org/10.1016/j.medengphy.2010.01.006
  25. Makin GS. The effect of surgical operation on the velocity of venous return from the legs. J Surg Res. 1970;10(11):513-518. https://doi.org/10.1016/0022-4804(70)90076-4
  26. Laberko L, Rodoman G, Barinov V, Lobastov K. Epidemiologiya venoznykh tromboembolii u khirurgicheskikh patsientov iz gruppy vysokogo riska i rol’ sural’nogo sinusa v initsiatsii tromboticheskogo protsessa. Khirurgiya. Zhurnal im. NI Pirogova. 2013;(6):38-43. (In Russ.)
  27. Nicolaides AN. Prevention of deep vein thrombosis. Geriatrics. 1973;28(2):69-77.
  28. Coleridge Smith PD, Hasty JH, Scurr JH. Deep vein thrombosis: effect of graduated compression stockings on distension of the deep veins of the calf. Br J Surg. 1991;78(6):724-726. https://doi.org/10.1002/bjs.1800780628
  29. Schaub RG, Lynch PR, Stewart GJ. The response of canine veins to three types of abdominal surgery: a scanning and transmission electron microscopic study. Surgery. 1978;83(4):411-424.
  30. Barinov V, Lobastov K, Schastlivtsev I, Tsaplin S, Laberko L, Brekhov E, Boyarintsev V. Prediktory razvitiya venoznykh tromboembolicheskikh oslozhnenii u operirovannykh patsientov iz gruppy vysokogo riska. Flebologiya. 2014;8(1):21-32. (In Russ.)
  31. Wang CJ, Wang JW, Weng LH, Huang CC, Yu PC. Clinical significance of muscular deep-vein thrombosis after total knee arthroplasty. Chang Gung Med J. 2007;30(1):41-46.
  32. Krunes U, Teubner K, Knipp H, Holzapfel R. Thrombosis of the muscular calf veins-reference to a syndrome which receives little attention. Vasa. 1998;27(3):172-175.
  33. Ohgi S, Tachibana M, Ikebuchi M, Kanaoka Y, Maeda T, Mori T. Pulmonary embolism in patients with isolated soleal vein thrombosis. Angiology. 1998;49(9):759-764. https://doi.org/10.1177/000331979804901008
  34. Labropoulos N, Webb KM, Kang SS, Mansour MA, Filliung DR, Size GP, Buckman J, Baker WH. Patterns and distribution of isolated calf deep vein thrombosis. J Vasc Surg. 1999;30(5):787-791. https://doi.org/10.1016/s0741-5214(99)70002-9
  35. Galanaud JP, Sevestre MA, Genty C, Laroche JP, Zizka V, Quere I, Bosson JL, investigators OS. Comparison of the clinical history of symptomatic isolated muscular calf vein thrombosis versus deep calf vein thrombosis. J Vasc Surg. 2010;52(4):932-938, 938 e1-e2. https://doi.org/10.1016/j.jvs.2010.05.019
  36. Brian S, Fries RB, Bhagwan S. Clinical characteristics of patients with isolated calf vein thrombosis in a large teaching hospital. Int J Vasc Med. 2011;2011:414093. https://doi.org/10.1155/2011/414093
  37. Yoshimura N, Hori Y, Horii Y, Takano T, Ishikawa H, Aoyama H. Where is the most common site of DVT? Evaluation by CT venography. Jpn J Radiol. 2012;30(5):393-397. https://doi.org/10.1007/s11604-012-0059-6
  38. Wessler S, Yin ET, Gaston LW, Nicol I. A distinction between the role of precursor and activated forms of clotting factors in the genesis of stasis thrombi. Thromb Diath Haemorrh. 1967;18(1-2):12-23.
  39. Wessler S, Yin ET. On the mechanism of thrombosis. Prog Hematol. 1969;6:201-232.
  40. Wessler S, Yin ET. Experimental hypercoagulable state induced by factor X: comparison of the nonactivated and activated forms. J Lab Clin Med. 1968;72(2):256-260.
  41. Lindberg F, Rasmussen I, Siegbahn A, Bergqvist D. Coagulation activation after laparoscopic cholecystectomy in spite of thromboembolism prophylaxis. Surg Endosc. 2000;14(9):858-861. https://doi.org/10.1007/s004640000213
  42. Fujii Y, Tanaka R, Takeuchi S, Koike T, Minakawa T, Sasaki O. Serial changes in hemostasis after intracranial surgery. Neurosurgery. 1994;35(1):26-33. https://doi.org/10.1097/00006123-199407000-00004
  43. Liu C, Guan Z, Xu Q, Zhao L, Song Y, Wang H. Relation of thromboelastography parameters to conventional coagulation tests used to evaluate the hypercoagulable state of aged fracture patients. Medicine (Baltimore). 2016; 95(24):e3934. https://doi.org/10.1097/MD.0000000000003934
  44. Katel’nitskaya OV, Kit OI, Gus’kova NK, Avanesova KA, Katel’nitskiy II, Soldatkina NV, Fomenko YuA, Petrov DS. Otsenka funktsional’nogo sostoyaniya svertyvayushchei sistemy v posleoperatsionnom periode u bol’nykh so zlokachestvennymi novoobrazovaniyami organov zheludochno-kishechnogo trakta. Izvestiya vysshikh uchebnykh zavedenii. Severo-Kavkazskii region. Estestvennye nauki. 2017;4-2(196-2):48-57. (In Russ.)
  45. Benyo M, Flasko T, Molnar Z, Kerenyi A, Batta Z, Jozsa T, Harsfalvi J. Follow-up of thrombin generation after prostate cancer surgery: global test for increased hypercoagulability. PLoS One. 2012;7(12):e51299. https://doi.org/10.1371/journal.pone.0051299
  46. Gary JL, Schneider PS, Galpi M, Radwan Z, Munz JW, Achor TS, Prasarn ML, Cotton BA. Can Thrombelastography Predict Venous Thromboembolic Events in Patients With Severe Extremity Trauma? J Orthop Trauma. 2016;30(6):294-298. https://doi.org/10.1097/BOT.0000000000000523
  47. McCrath DJ, Cerboni E, Frumento RJ, Hirsh AL, Bennett-Guerrero E. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg. 2005;100(6):1576-1583. https://doi.org/10.1213/01.ANE.0000155290.86795.12
  48. Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost. 2003;29(2):125-130. https://doi.org/10.1055/s-2003-38897
  49. Kemmeren JM, Algra A, Meijers JC, Tans G, Bouma BN, Curvers J, Rosing J, Grobbee DE. Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor V Leiden mutation: a randomized trial. Blood. 2004;103(3):927-933. https://doi.org/10.1182/blood-2003-04-1285
  50. Eilertsen AL, Hoibraaten E, Os I, Andersen TO, Sandvik L, Sandset PM. The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis. Maturitas. 2005;52(2):111-118. https://doi.org/10.1016/j.maturitas.2005.01.004
  51. Middeldorp S. Oral contraceptives and the risk of venous thromboembolism. Gend Med. 2005;2 Suppl A:S3-S9. https://doi.org/10.1016/s1550-8579(05)80059-2
  52. Post MS, Christella M, Thomassen LG, van der Mooren MJ, van Baal WM, Rosing J, Kenemans P, Stehouwer CD. Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women. Arterioscler Thromb Vasc Biol. 2003;23(6):1116-1121. https://doi.org/10.1161/01.ATV.0000074146.36646.C8
  53. Hirmerová J. Homocysteine and venous thromboembolism — Is there any link? Cor et Vasa. 2013;55(3):e248-e258. https://doi.org/10.1016/j.crvasa.2013.01.007
  54. Harper BE, Wills R, Pierangeli SS. Pathophysiological mechanisms in antiphospholipid syndrome. Int J Clin Rheumtol. 2011;6(2):157-171. https://doi.org/10.2217/ijr.11.9
  55. Mackworth-Young CG. Antiphospholipid syndrome: multiple mechanisms. Clin Exp Immunol. 2004;136(3):393-401. https://doi.org/10.1111/j.1365-2249.2004.02497.x
  56. Espinosa G, Cervera R, Font J, Reverter J, Shoenfeld Y. Mechanisms of thrombosis in the antiphospholipid syndrome. Immunología. 2003;22:53-62.
  57. Agnelli G, Bolis G, Capussotti L, Scarpa RM, Tonelli F, Bonizzoni E, Moia M, Parazzini F, Rossi R, Sonaglia F, Valarani B, Bianchini C, Gussoni G. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the RISTOS project. Ann Surg. 2006;243(1):89-95. https://doi.org/10.1097/01.sla.0000193959.44677.48
  58. Bergqvist D. Risk of venous thromboembolism in patients undergoing cancer surgery and options for thromboprophylaxis. J Surg Oncol. 2007;95(2):167-174. https://doi.org/10.1002/jso.20625
  59. Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005;293(6):715-722. https://doi.org/10.1001/jama.293.6.715
  60. Blom JW, Vanderschoot JP, Oostindier MJ, Osanto S, van der Meer FJ, Rosendaal FR. Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost. 2006;4(3):529-535. https://doi.org/10.1111/j.1538-7836.2006.01804.x
  61. Donnellan E, Khorana AA. Cancer and Venous Thromboembolic Disease: A Review. Oncologist. 2017;22(2):199-207. https://doi.org/10.1634/theoncologist.2016-0214
  62. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ 3rd. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000;160(6):809-815. https://doi.org/10.1001/archinte.160.6.809
  63. Schmaier AA, Ambesh P, Campia U. Venous Thromboembolism and Cancer. Curr Cardiol Rep. 2018;20(10):89. https://doi.org/10.1007/s11886-018-1034-3
  64. Mousa SA, Petersen LJ. Anti-cancer properties of low-molecular-weight heparin: preclinical evidence. Journal of Thrombosis and Haemostasis. 2009;102(2):258-267. https://doi.org/10.1160/TH08-12-0832
  65. Falanga A, Marchetti M, Vignoli A. Coagulation and cancer: biological and clinical aspects. Journal of Thrombosis and Haemostasis. 2013;11(2):223-233. https://doi.org/10.1111/jth.12075
  66. Wakefield TW, Myers DD, Henke PK. Mechanisms of Venous Thrombosis and Resolution. Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28(3):387-391. https://doi.org/10.1161/atvbaha.108.162289
  67. Lipets E, Vlasova O, Urnova E, Margolin O, Soloveva A, Ostapushchenko O, Andersen J, Ataullakhanov F, Panteleev M. Circulating contact-pathway-activating microparticles together with factors IXa and XIa induce spontaneous clotting in plasma of hematology and cardiologic patients. PLoS One. 2014;9(1):e87692. https://doi.org/10.1371/journal.pone.0087692
  68. Ghozlan MF, Osman AA, Mahmoud HM, Eissa DG, Abuelela S. Comprehensive study on laboratory biomarkers for prediction and diagnosis of deep venous thrombosis. Blood Coagul Fibrinolysis. 2015;26(3):255-260. https://doi.org/10.1097/MBC.0000000000000164
  69. Rectenwald JE, Myers DDJr, Hawley AE, Longo C, Henke PK, Guire KE, Schmaier AH, Wakefield TW. D-dimer, P-selectin, and microparticles: novel markers to predict deep venous thrombosis. A pilot study. Thromb Haemost. 2005;94(6):1312-1317. https://doi.org/10.1160/TH05-06-0426
  70. Chirinos JA, Heresi GA, Velasquez H, Jy W, Jimenez JJ, Ahn E, Horstman LL, Soriano AO, Zambrano JP, Ahn YS. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol. 2005;45(9):1467-1471. https://doi.org/10.1016/j.jacc.2004.12.075
  71. Geddings JE, Mackman N. Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood. 2013;122(11):1873-1880. https://doi.org/10.1182/blood-2013-04-460139
  72. Cesarman-Maus G, Braggio E, Maldonado H, Fonseca R. Absence of tissue factor expression by neoplastic plasma cells in multiple myeloma. Leukemia. 2012;26(7):1671-1674. https://doi.org/10.1038/leu.2012.43
  73. Sautina EV, Dement’eva GI, Soshitova NP, Korotaev AL, Bargandzhiya AB, Gritskova IV, Lobastov KV. Vozmozhnosti vyyavleniya i klinicheskoe znachenie bazal’noi giperkoagulyatsii u bol’nykh s kolorektal’nym rakom. Khirurg. 2018;164(9-10):35-47. (In Russ.)
  74. Gracheva MA, Urnova ES, Sinauridze EI, Tarandovskiy ID, Orel EB, Poletaev AV, Mendeleeva LP, Ataullakhanov FI, Balandina AN. Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma. Leuk Lymphoma. 2015;56(12):3418-3425. https://doi.org/10.3109/10428194.2015.1041385
  75. Liu J, Wang N, Chen Y, Lu R, Ye X. Thrombelastography coagulation index may be a predictor of venous thromboembolism in gynecological oncology patients. J Obstet Gynaecol Res. 2017;43(1):202-210. https://doi.org/10.1111/jog.13154
  76. Mannucci PM, Franchini M. Classic thrombophilic gene variants. Thromb Haemost. 2015;114(5):885-889. https://doi.org/10.1160/TH15-02-0141
  77. Franchini M, Martinelli I, Mannucc PM. Uncertain thrombophilia markers. Thromb Haemost. 2016;115(1):25-30. https://doi.org/10.1160/TH15-06-0478
  78. Stevens SM, Woller SC, Bauer KA, Kasthuri R, Cushman M, Streiff M, Lim W, Douketis JD. Guidance for the evaluation and treatment of hereditary and acquired thrombophilia. J Thromb Thrombolysis. 2016;41(1):154-164. https://doi.org/10.1007/s11239-015-1316-1
  79. Kearon C. Influence of hereditary or acquired thrombophilias on the treatment of venous thromboembolism. Curr Opin Hematol. 2012;19(5):363-370. https://doi.org/10.1097/MOH.0b013e328356745b
  80. Connors JM. Thrombophilia Testing and Venous Thrombosis. N Engl J Med. 2017;377(12):1177-1187. https://doi.org/10.1056/NEJMra1700365
  81. Eikelboom JW, Ivey L, Ivey J, Baker RI. Familial thrombophilia and the prothrombin 20210A mutation: association with increased thrombin generation and unusual thrombosis. Blood Coagul Fibrinolysis. 1999;10(1):1-5. https://doi.org/10.1097/00001721-199901000-00001
  82. Kyrle PA, Mannhalter C, Beguin S, Stumpflen A, Hirschl M, Weltermann A, Stain M, Brenner B, Speiser W, Pabinger I, Lechner K, Eichinger S. Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene. Arterioscler Thromb Vasc Biol. 1998;18(8):1287-1291. https://doi.org/10.1161/01.atv.18.8.1287
  83. Simioni P, Tormene D, Luni S, Caldato M, Girolami A. Clinical and laboratory expression of associated thrombophilic conditions (homozygous/heterozygous factor V Leiden mutation and heterozygous prothrombin variant 20210A) in an Italian family. Blood Coagul Fibrinolysis. 2000;11(4):379-384. https://doi.org/10.1097/00001721-200006000-00010
  84. O’Donnell J, Riddell A, Owens D, Handa A, Pas J, Hamilton G, Perry DJ. Role of the Thrombelastograph as an adjunctive test in thrombophilia screening. Blood Coagul Fibrinolysis. 2004;15(3):207-211. https://doi.org/10.1097/00001721-200404000-00002
  85. Hezard N, Bouaziz-Borgi L, Remy MG, Nguyen P. Utility of thrombin-generation assay in the screening of factor V G1691A (Leiden) and prothrombin G20210A mutations and protein S deficiency. Clin Chem. 2006;52(4):665-670. https://doi.org/10.1373/clinchem.2005.063339
  86. Wu M, Thiagarajan M. Role of endothelium in thrombosis and hemostasis. Annual review of medicine. 1996;47(1):315-331. https://doi.org/10.1146/annurev.med.47.1.315
  87. Rajendran P, Rengarajan T, Thangavel J, Nishigaki Y, Sakthisekaran D, Sethi G, Nishigaki I. The vascular endothelium and human diseases. International journal of biological sciences. 2013;9(10):1057. https://doi.org/10.7150/ijbs.7502
  88. Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol. 2007;49(25):2379-2393. https://doi.org/10.1016/j.jacc.2007.02.059
  89. Papaioannou TG, Stefanadis C. Vascular wall shear stress: basic principles and methods. Hellenic J Cardiol. 2005;46(1):9-15.
  90. Suchkov IA. Korrektsiya endotelial’noi disfunktsii: sovremennoe sostoyanie problemy (obzor literatury). Rossiiskii mediko-biologicheskii vestnik im. akad. I.P. Pavlova.. 2012;(4):151-156. (In Russ.)
  91. Brill A, Fuchs TA, Chauhan AK, Yang JJ, De Meyer SF, Kollnberger M, Wakefield TW, Lammle B, Massberg S, Wagner DD. Von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood. 2011;117(4):1400-1407. https://doi.org/10.1182/blood-2010-05-287623
  92. Schulz C, Engelmann B, Massberg S. Crossroads of coagulation and innate immunity: the case of deep vein thrombosis. J Thromb Haemost. 2013;11 (Suppl 1):233-241. https://doi.org/10.1111/jth.12261
  93. Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DDJr, Wrobleski SK, Wakefield TW, Hartwig JH, Wagner DD. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci USA. 2010;107(36):15880-15885. https://doi.org/10.1073/pnas.1005743107
  94. Giesen PL, Rauch U, Bohrmann B, Kling D, Roque M, Fallon JT, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA. 1999;96(5):2311-2315. https://doi.org/10.1073/pnas.96.5.2311
  95. Biro E, Sturk-Maquelin KN, Vogel GM, Meuleman DG, Smit MJ, Hack CE, Sturk A, Nieuwland R. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost. 2003;1(12):2561-2568. https://doi.org/10.1046/j.1538-7836.2003.00456.x
  96. Hoffman M, Monroe DM3rd. A cell-based model of hemostasis. Thromb Haemost. 2001;85(6):958-965. https://doi.org/10.1055/s-0037-1615947
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.